Abstract:

Clinical and basic science research in endometriosis has been severely hampered by the lack of accurate noninvasive diagnostic tools. The advent of powerful genomic and proteomic technology may help elucidate the etiology and pathophysiology of this complex and enigmatic disease and open new avenues for diagnosis and treatment. Genomic techniques have demonstrated that certain gene products are abnormally expressed in endometriotic tissues.

Authors:

Arezou Azarani, Ph.D. - Protogen, Palo Alto, California; Joelle Osias , M.D. - Stanford University School of Medicine, Department of OB/Gyn, Palo Alto, California; Bulent Berker, M.D. - Stanford University Medical Center, Palo Alto, California; Ceana Nezhat, M.D., F.A.C.O.G., F.A.C.S. - Gynecology, Endocrinology, Endometriosis & Infertility, Nezhat Medical Center, Atlanta, Georgia; Camran Nezhat, M.D., F.A.C.O.G, F.A.C.S. - Stanford University Medical School, Stanford University, Center for Special Minimally Invasive Surgery, Palo Alto, California

For Direct IP Access please click this link